High seroprevalence of anti-SARS-CoV-2 antibodies in the capital city of Chad | Deutou Wondeu Andrillene Laure

Approaches to Combat COVID-19 in Low- and Middle-Income Countries Workshop 2022

SARS-CoV-2 Genomic Surveillance and Reliability of PCR Point Mutation Assay (EscapePLEX kit) for the Rapid Detection of Variants of Concern in Cameroon | Davy Hyacinthe Gouissi Anguechia

Approaches to Combat COVID-19 in Low- and Middle-Income Countries Workshop 2022

Viral dynamics and factors favouring the duration of covid-19 positivity: Evidence from the first-three epidemiological waves in Cameroon | Aurelie Minelle Kengni Ngueko

Approaches to Combat COVID-19 in Low- and Middle-Income Countries Workshop 2022

The Omicron Variant: Lessons Learned & Preparedness for Next Waves | Laila Woc-Colburn, MD, DTM&H, FIDSA

Approaches to Combat COVID-19 in Low- and Middle-Income Countries Workshop 2022

A Multinational Delphi Consensus to End the COVID-19 Public Health Threat | Jeffrey Lazarus, PhD, MIH, MA

Approaches to Combat COVID-19 in Low- and Middle-Income Countries Workshop 2022

Vaccine Landscape | Kathryn Stephenson, MD, MPH

Approaches to Combat COVID-19 in Low- and Middle-Income Countries Workshop 2022

Clinical Management of Long COVID | Carlos del Rio, MD

Approaches to Combat COVID-19 in Low- and Middle-Income Countries Workshop 2022

Clinical Management of COVID-19 in High-risk Populations | Claudia Cortes, MD

Approaches to Combat COVID-19 in Low- and Middle-Income Countries Workshop 2022